Table 1.
Patient characteristics development cohort.
| Parameter | Survivors (N=559) | Non-survivors (N=120) |
|---|---|---|
| % / Median (lQR) | % / Median (IQR) | |
| Sex | ||
| Female | 40 | 36 |
| Male | 60 | 64 |
| Age (years) | 58 (44-72) | 81 (77-89) |
| BMI | 27 (24-31) | 26 (25-32) |
| Comorbidities | ||
| Current smoker | 8 | 10 |
| Overweight (BMI > 25) | 62 | 64 |
| Diabetes type II | 18 | 36 |
| Hypertension | 45 | 74 |
| Coronary heart disease | 12 | 30 |
| Chronic heart failure | 6 | 26 |
| Atrial fibrillation | 14 | 38 |
| Peripheral arterial disease | 5 | 14 |
| Chronic obstructive pulmonary disease | 11 | 14 |
| Asthma | 4 | 6 |
| Hypo- / Hyperthyroidism | 8 | 10 |
| Chronic renal insufficiency | 10 | 44 |
| Chronic liver disease | 4 | 6 |
| Malignancy | 9 | 18 |
| Symptoms at admission | ||
| Asymptomatic | 12 | 2 |
| Fatigue | 57 | 67 |
| Cough | 61 | 51 |
| Fever | 52 | 60 |
| Requirement of oxygen | 35 | 70 |
| Dyspnea | 43 | 41 |
| Diarrhea | 16 | 6 |
| Sore throat | 14 | 0 |
| Nausea or vomiting | 7 | 0 |
| Predictors upon admission | ||
| Platelet count (103/ µI) | 195 (154-264) | 178 (138-220) |
| CRP (mg/l) | 49 (25-88) | 60 (33-169) |
| Creatinine (mg/dl) | 0.9 (0.8 - 1.1) | 1.4 (1.1-1.8) |
| LDH (U/l) | 283 (231-379) | 326 (237-370) |